Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-tyrosine is the D-enantiomer of tyrosine, a non-essential amino acid that serves as a precursor to key neurotransmitters such as dopamine, norepinephrine, and epinephrine. It is synthesized from phenylalanine in animals and also acts as a precursor for thyroid hormones and melanin[2][1]. While L-tyrosine is commonly found in proteins and used in dietary supplements, D-tyrosine has been studied primarily for its experimental roles. These include potential applications in mood enhancement, cognitive function support, stress management, sports nutrition (for reducing fatigue), skin health (via melanin production), and inhibition of bacterial biofilm formation[1][6]. In pharmaceutical development, it has been investigated for treating conditions like depression and anxiety[1]. Mechanistically, D-tyrosine can influence neurotransmitter synthesis pathways and may act on amino acid transporters involved in thyroid hormone homeostasis[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on D-tyrosine.